Fifth Third Bancorp’s Amicus Therapeutics FOLD Stock Holding History

Fifth Third Bancorp’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,593	Closed	-$37.5K	–	4382
2026 Q1	$37.5K	Buy	+2,593	New	+$37.2K	﹤0.01%	3300
2025 Q4	–	Sell	-100	Closed	-$788	–	2668
2025 Q3	$788	Buy	+100	New	+$712	﹤0.01%	2560
2021 Q4	–	Sell	-213	Closed	-$2K	–	2709
2021 Q3	$2K	Hold	213	–	–	﹤0.01%	2448
2021 Q2	$2K	Sell	213 -573	-73%	-$5.59K	﹤0.01%	2334
2021 Q1	$8K	Sell	786 -196	-20%	-$3.03K	﹤0.01%	2069
2020 Q4	$23K	Sell	982 -8,419	-90%	-$172K	﹤0.01%	1665
2020 Q3	$133K	Buy	+9,401	New	+$137K	﹤0.01%	1018
2019 Q4	–	Sell	-289	Closed	-$2K	–	2245
2019 Q3	$2K	Buy	+289	New	+$3.14K	﹤0.01%	2051
2019 Q1	–	Sell	-965	Closed	-$9K	–	2200
2018 Q4	$9K	Buy	+965	New	+$10.6K	﹤0.01%	1803

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Fifth Third Bancorp's FOLD Position: Q2 2026 in Review

Fifth Third Bancorp sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 2,593 shares — an estimated $37.5K sold.

Fifth Third Bancorp first reported a position in FOLD in Q4 2018 and held it in 9 quarters. The position peaked at $133K in Q3 2020. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Fifth Third Bancorp reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Fifth Third Bancorp sold 2,593 Amicus Therapeutics shares in Q2 2026, an estimated $37.5K.
Fifth Third Bancorp first reported a position in Amicus Therapeutics in Q4 2018 and held it in 9 quarters.
Fifth Third Bancorp's Amicus Therapeutics position peaked at $133K in Q3 2020.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.